Year-over-year earnings per share growth for the last twelve months: gtglabs.com (GENE)

Genetic Technologies Limited - graphic logo of issuer GENE

This quarterly earnings per share chart demonstrates the financial dynamics of Genetic Technologies (GENE), where the value 39.40 captures the metric level. Genetic Technologies aims to implement PRS tests for the early diagnosis of cancer and heart disease. These innovations are based on AI DNA analysis algorithms for preventive medicine, while cloud IT services are delegated to external partners under strict adherence to security protocols.

gtglabs.com (GENE) - Net earnings per share growth for the trailing year from 07/04/2022 to 10/26/2024
Manufactured product of Genetic Technologies

To distinguish a sustainable business from speculative capital, analyzing the dynamics of net earnings per share is critical, as it measures the real pace of value generation per ownership stake. The quarterly percentage change in EPS allows for an assessment of how the digital genetic testing ecosystem and B2B integration with the AI platform mitigate market risks, confirming the fundamental viability of the Genetic Technologies (GENE) model during periods of economic contraction.

Competitor analysis for Genetic Technologies

A: Quarterly EPS earnings growth|DGX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Illumina Corp|Exact Sciences Inc. (EXAS) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth RVTY|bio-rad.com (BIO) - Net earnings per share growth for the trailing year|Quarterly EPS earnings growth NNNN (Anbio)|Sotera Health Corp (SHC) - Earnings per share growth in annualized terms for the last twelve months|QDEL - Year-over-year earnings per share growth for the last twelve months|OPK (OPKO Health Corp.) - Year-over-year earnings per share growth for the last 12 months|CDNA: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months maravai.com (MRVI)|Year-over-year net earnings per share growth for the last 12 months FLGT|LAB (Standard BioTools Inc) - Year-over-year earnings per share growth rate for the last twelve months|Quarterly EPS earnings growth CTKB|Year-over-year net earnings per share change for the last twelve months OraSure Corp|Quarterly EPS earnings growth XGN (Exagen)|MDXH - Year-over-year net earnings per share growth for the last 12 months|LUCD: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months PRE (Prenetics Global)|IMDX (imdxinc.com) - Year-over-year net earnings per share growth for the last 12 months|TRIB: Year-over-year earnings per share growth rate for the last twelve months|PRPH (ProPhase Labs, Inc.) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months ainos.com AIMD|Quarterly EPS earnings growth CODX|Year-over-year net earnings per share growth for the last 12 months Heart Test Laboratories, Inc. HSCS|Quarterly EPS earnings growth BMRA (Biomerica, Inc)|Year-over-year earnings per one share growth for the last 12 months CDIO|ONCO - Year-over-year earnings per share growth for the last twelve months|VRAX (viraxbiolabs.com) - Year-over-year earnings per share growth for the last 12 months|Bluejay Diagnostics, Inc. (BJDX) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Aspira Women's Health, Inc. (AWH)|Year-over-year earnings per share growth for the last twelve months Accelerate Diagnostics, Inc|Year-over-year earnings per share growth for the last twelve months CNTG|Year-over-year earnings per share growth for the last twelve months Enzo Biochem, Inc. (ENZ)|FRES - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth ME (23andMe)|Net earnings per share growth for the trailing year Psychemedics Corp.